Mr. Steven Lynn Mackey, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 125 Alison Dr, Suite 8, Alexander City, AL 35010 Phone: 256-409-2159 Fax: 256-409-2178 |
News Archive
A new study carried out by the Bellvitge Biomedical Research Institute and the Institute of Global Health of Barcelona, a centre supported by "la Caixa" Foundation, associates for the first time mild obsessive-compulsive symptoms, which are present in a much higher percentage of cases than those that require specialized medical and psychological attention, to characteristics and specific alterations of the cerebral anatomy.
Experiments at the Pioneer Valley Life Sciences Institute (PVLSI) at Baystate Medical Center in Springfield, Mass., reported in a recent British Journal of Cancer, confirm that University of Massachusetts Amherst chemical engineer Neil Forbes' delivery and trigger system has for the first time successfully placed TRAIL, a cancer-fighting protein, directly into solid tumors and on cue, turned it on. The treatment improved the 30-day survival time of mice with mammary tumors from 0 to 100 percent.
Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc., announced the successful filing of an Investigational New Drug Application for IPX159 in Restless Legs Syndrome and initiated a Phase I study.
Selecting treatments according to genetic differences could help children and teenagers with asthma, according to research presented at the European Respiratory Society International Congress.
› Verified 8 days ago